Decreasing 25-hydroxy-vitamin D levels account for portion of the effect of increasing body mass index on breast cancer mortality

Molecular Nutrition and Food Research

Volumn 57, Issue 2, 2013, Pages 260-266

  Morton, Matthew L ^a   Thompson, Cheryl L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BMI; Breast cancer; Cancer mortality; Obesity; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ARTICLE; BLOOD; BODY MASS; BREAST TUMOR; DIET SUPPLEMENTATION; FEMALE; HUMAN; META ANALYSIS (TOPIC); MORTALITY; OBESITY; RISK FACTOR; VITAMIN D DEFICIENCY;

BODY MASS INDEX; BREAST NEOPLASMS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; META-ANALYSIS AS TOPIC; OBESITY; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84872812544     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200405     Document Type: Article

References (46)

1. DeSantis, C., Siegel, R., Bandi, P., Jemal, A., Breast cancer statistics, 2011. CA Cancer J. Clin. 2011, 61, 409-418.
2. Dignam, J. J., Wieand, K., Johnson, K. A., Raich, P. et al., Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res. Treat. 2006, 97, 245-254.
3. Caan, B. J., Kwan, M. L., Hartzell, G., Castillo, A. et al., Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control 2008, 19, 1319-1328.
4. Chen, X., Lu, W., Zheng, W., Gu, K. et al., Obesity and weight change in relation to breast cancer survival. Breast Cancer Res. Treat. 2010, 122, 823-833.
5. Emaus, A., Veierod, M. B., Tretli, S., Finstad, S. E. et al., Metabolic profile, physical activity, and mortality in breast cancer patients. Breast Cancer Res. Treat. 2010, 121, 651-660.
6. Hauner, D., Janni, W., Rack, B., Hauner, H., The effect of overweight and nutrition on prognosis in breast cancer. Dtsch. Arztebl. Int. 2011, 108, 795-801.
7. Carmichael, A. R., Obesity and prognosis of breast cancer. Obes. Rev. 2006, 7, 333-340.
8. McTiernan, A., Irwin, M., Vongruenigen, V., Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J. Clin. Oncol. 2010, 28, 4074-4080.
9. Society, A. C., Breast Cancer Facts & Figures 2011-2012, American Cancer Society, Inc., Atlanta 2011.
10. Vrieling, A., Hein, R., Abbas, S., Schneeweiss, A. et al., Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res. 2011, 13, R74.
11. Protani, M., Coory, M., Martin, J. H., Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res. Treat. 2010, 123, 627-635.
12. Cleveland, R. J., Eng, S. M., Abrahamson, P. E., Britton, J. A. et al., Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 1803-1811.
13. Barnett, G. C., Shah, M., Redman, K., Easton, D. F. et al., Risk factors for the incidence of breast cancer: do they affect survival from the disease? J. Clin. Oncol. 2008, 26, 3310-3316.
14. Bolland, M. J., Grey, A., Gamble, G. D., Reid, I. R., Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am. J. Clin. Nutr. 2011, 94, 1144-1149.
15. Khan, Q. J., Kimler, B. F., Fabian, C. J., The relationship between vitamin D and breast cancer incidence and natural history. Curr. Oncol. Rep. 2010, 12, 136-142.
16. Mohr, S. B., Gorham, E. D., Alcaraz, J. E., Kane, C. J. et al., Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. Anticancer Res. 2011, 31, 2939-2948.
17. Shin, M. H., Holmes, M. D., Hankinson, S. E., Wu, K. et al., Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J. Natl. Cancer Inst. 2002, 94, 1301-1311.
18. Welsh, J., Vitamin D and prevention of breast cancer. Acta Pharmacol. Sin. 2007, 28, 1373-1382.
19. Yin, L., Grandi, N., Raum, E., Haug, U. et al., Meta-analysis: serum vitamin D and breast cancer risk. Eur. J. Cancer 2010, 46, 2196-2205.
20. Gandini, S., Boniol, M., Haukka, J., Byrnes, G. et al., Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int. J. Cancer 2011, 128, 1414-1424.
21. Grant, W. B., Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J. Photochem. Photobiol. B 2010, 101, 130-136.
22. Almquist, M., Bondeson, A. G., Bondeson, L., Malm, J., Manjer, J., Serum levels of vitamin D, PTH and calcium and breast cancer risk-a prospective nested case-control study. Int. J. Cancer 2010, 127, 2159-2168.
23. Amir, E., Cecchini, R. S., Ganz, P. A., Costantino, J. P. et al., 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1. Breast Cancer Res. Treat. 2012, 133, 1077-1088.
24. Robsahm, T. E., Tretli, S., Dahlback, A., Moan, J., Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 2004, 15, 149-158.
25. Porojnicu, A. C., Lagunova, Z., Robsahm, T. E., Berg, J. P. et al., Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Res. Treat. 2007, 102, 323-328.
26. Goodwin, P. J., Ennis, M., Pritchard, K. I., Koo, J., Hood, N., Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J. Clin. Oncol. 2009, 27, 3757-3763.
27. Freedman, D. M., Looker, A. C., Chang, S. C., Graubard, B. I., Prospective study of serum vitamin D and cancer mortality in the United States. J. Natl. Cancer Inst. 2007, 99, 1594-1602.
28. Jacobs, E. T., Thomson, C. A., Flatt, S. W., Al-Delaimy, W. K. et al., Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study. Am. J. Clin. Nutr. 2011, 93, 108-117.
29. Neuhouser, M. L., Sorensen, B., Hollis, B. W., Ambs, A. et al., Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am. J. Clin. Nutr. 2008, 88, 133-139.
30. Koga, M., Eisman, J. A., Sutherland, R. L., Regulation of epidermal growth factor receptor levels by 1, 25-dihydroxyvitamin D3 in human breast cancer cells. Cancer Res. 1988, 48, 2734-2739.
31. Ingraham, B. A., Bragdon, B., Nohe, A., Molecular basis of the potential of vitamin D to prevent cancer. Curr. Med. Res. Opin. 2008, 24, 139-149.
32. Lopes, N., Sousa, B., Martins, D., Gomes, M. et al., Alterations in vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer 2010, 10, 483.
33. Garland, C. F., Garland, F. C., Gorham, E. D., Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann. N. Y. Acad. Sci. 1999, 889, 107-119.
34. Lagunova, Z., Porojnicu, A. C., Lindberg, F., Hexeberg, S., Moan, J., The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res. 2009, 29, 3713-3720.
35. Vashi, P. G., Lammersfeld, C. A., Braun, D. P., Gupta, D., Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer. Nutr. J. 2011, 10, 51.
36. McGill, A. T., Stewart, J. M., Lithander, F. E., Strik, C. M., Poppitt, S. D., Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr. J. 2008, 7, 4.
37. Rodriguez-Rodriguez, E., Navia, B., Lopez-Sobaler, A. M., Ortega, R. M., Vitamin D in overweight/obese women and its relationship with dietetic and anthropometric variables. Obesity (Silver Spring) 2009, 17, 778-782.
38. Stein, E. M., Strain, G., Sinha, N., Ortiz, D. et al., Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study. Clin. Endocrinol. (Ox.) 2009, 71, 176-183.
39. Lagunova, Z., Porojnicu, A. C., Grant, W. B., Bruland, O., Moan, J. E., Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association? Mol. Nutr. Food Res. 2010, 54, 1127-1133.
40. Drincic, A. T., Armas, L. A., Van Diest, E. E., Heaney, R. P., Volumetric dilution, rather than sequestration best explains the low vitamin d status of obesity. Obesity (Silver Spring) 2012, 20, 1444-1448.
41. Earthman, C. P., Beckman, L. M., Masodkar, K., Sibley, S. D., The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int. J. Obes. (Lond) 2012, 36, 387-396.
42. Kamycheva, E., Joakimsen, R. M., Jorde, R., Intakes of calcium and vitamin d predict body mass index in the population of Northern Norway. J. Nutr. 2003, 133, 102-106.
43. Florez, H., Martinez, R., Chacra, W., Strickman-Stein, N., Levis, S., Outdoor exercise reduces the risk of hypovitaminosis D in the obese. J. Steroid. Biochem. Mol. Biol. 2007, 103, 679-681.
44. Grant, W. B., Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate. Dermatoendocrinol 2012, 4, 1-5.
45. Garland, C. F., French, C. B., Baggerly, L. L., Heaney, R. P., Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res. 2011, 31, 607-611.
46. Goodwin, P. J., Vitamin D in cancer patients: above all, do no harm. J. Clin. Oncol. 2009, 27, 2117-2119.